Loading company
Clearmind Medicine Inc.
CMND · Nasdaq · ·
$0.79-1.4%Sep 28 close
- 1M
- -55.0%
- 6M
- -92.1%
- 1Y
- -99.8%
CMND · Nasdaq · ·
$0.79-1.4%Sep 28 close
The quarter ending January 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toJan 31, 2026 | 3 months toJan 31, 2025 | Change |
|---|---|---|---|
| Profit | -$3.9M | -$1.1M | -259.70% |
| Profit per share | -$3.32 | -$0.28 | -1,085.71% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
The quote and the company description come from the 6-K Clearmind Medicine Inc. filed on September 10, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Clearmind Medicine Inc. has no earnings call transcript available.